Delivery Order SPE2DE24D0013-SPE2D625F5X8K
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,968.80 by the Defense Logistics Agency's Medical Supply Chain on April 23, 2025, with an ultimate completion date of May 7, 2025. This delivery order, which carries no set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic equipment and testing solutions to federal healthcare systems. The contract is likely...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,654.60 firm fixed-price delivery order (Contract No. GXCT/NG-10) by the Defense Logistics Agency's Medical Supply Chain division on May 6, 2025, with an ultimate completion date of May 13, 2025. The contract carries no set-aside designation and will be performed in Sunnyvale, California. This delivery order represents a continuation of Cepheid's ongoing relationship with the federal...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F5X8KDelivery Order
Cepheid has been awarded a delivery order valued at $4,078.80 by the Defense Logistics Agency's Medical Supply Chain division for performance in Sunnyvale, California. This firm fixed-price delivery order, issued on May 2, 2025 with an ultimate completion date of May 9, 2025, carries no set-aside designation. As a leading manufacturer of molecular diagnostic solutions, Cepheid specializes in GeneXpert diagnostic systems and related reagents, with a track record of supplying infectious disease testing capabilities to federal healthcare systems. This delivery order represents work under one of Cepheid's existing Indefinite Delivery Vehicle contracts, likely stemming from the company's broader federal partnerships focused on molecular diagnostic testing. Cepheid maintains significant IDV vehicles with the Veterans Affairs system, including a $32.8 million contract with VA's Veterans Integrated Service Network 6 for diagnostic testing reagents and assays through 2030. The company's federal contract portfolio emphasizes point-of-care diagnostics for conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases, positioning Cepheid as a key supplier of diagnostic capabilities across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 5/2/25 |